Rising out-of-pocket costs for dementia and neuropathy drugs lower patient adherence

As out-of-pocket costs rise for medicines used to treat certain neurologic disorders — such as dementia and neuropathy — patients are less likely to take their drugs as often as prescribed, according to a new study. And the findings are the latest indication that increasing drug costs may lead to worsening health and, consequently, higher health care expenses in the future.